Puma Biotechnology Inc. (PBYI) said it will delay filing for U.S. regulatory approval of its experimental breast cancer treatment by as much as a year. The company’s shares fell 15 percent to $192.36 at 9:36 a.m. in New York, the most since June. The drugmaker announced yesterday that it would apply for Food and Drug [...]
http://www.forbes.com/sites/johnlamattina/2014/12/02/the-debate-over-the-cost-to-develop-a-new-drug/?partner=yahootix
Studyops, San Francisco California, is aggressively seeking a Rheumatologist to become the lead investigator on Clinical Trials. There are currently 1800 studies for RA listed on clinicaltrials.gov and 500 for Lupis. This is a huge area of development in the R&D space and an excellent opportunity for a Rheumatologist to participate in the advancement of [...]
Ref: PR Newswire, Financial Times, Bloomberg, Yahoo!Finance, The Wall Street Journal, The New York Times, ABC News, Otsuka) December 2nd, 2014 By: Matthew Dennis Otsuka announced Tuesday a definitive agreement to acquire Avanir Pharmaceuticals for $17.00 per share in cash, or approximately $3.5 billion, expanding its presence in neurologic diseases. The transaction, which has been [...]
http://timesofindia.indiatimes.com/home/science/HIV-losing-its-edge-evolving-into-milder-form-study-finds/articleshow/45349074.cms
The Biggest HIV/AIDS Research Breakthroughs Of 2014 http://www.huffingtonpost.com/2014/12/01/2014-hiv-aids-research_n_6251388.html
http://www.forbes.com/sites/johnlamattina/2014/12/01/should-the-fda-force-drug-makers-to-discuss-their-clinical-trials/ Companies are not required to meet with the FDA to discuss their trial design. Nor are they required to follow their recommendations. As revealed in a recent research letter to the Journal of the American Medical Association (JAMA) ), of the 35 drugs approved from February 1, 2011 to February 29, 2012, companies met [...]
